Jon Marc Wigginton's Net Worth

$3.7 Million

Estimate Recalculated Sep 15, 2025 08:39PM EST

Who is Jon Marc Wigginton

Jon Marc Wigginton has an estimated net worth of $3.7 Million. This is based on reported shares across multiple companies, which include MACROGENICS INC, Cullinan Management, Inc., SUTRO BIOPHARMA, INC., and Checkmate Pharmaceuticals, Inc..

SEC CIK

Jon Marc Wigginton's CIK is 0001587487

Past Insider Trading and Trends

2015 was Jon Marc Wigginton's most active year for acquiring shares with 7 total transactions. Jon Marc Wigginton's most active month to acquire stocks was the month of September. 2015 was Jon Marc Wigginton's most active year for disposing of shares, totalling 14 transactions. Jon Marc Wigginton's most active month to dispose stocks was the month of September. 2017 saw Jon Marc Wigginton paying a total of $1,550,275.00 for 102,500 shares, this is the most they've acquired in one year. In 2016 Jon Marc Wigginton cashed out on 110,000 shares for a total of $1,634,900.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MACROGENICS INC

Sr VP, Clinical Dev. & CMO
Updated Feb 24, 2020
Form 4
100.00K
$11.50
$1.15M
Feb 24, 2020
100.00K
Grant
Feb 20
Form 4
90.00K
Feb 25, 2019
90.00K
Grant
Feb 21
Form 4
70.00K
Mar 06, 2018
70.00K
Grant
Mar 02
Form 4
-36.90%
-11.07K
$23.46
-$259.70K
Feb 27, 2018
18.93K
Tax
Feb 26
Form 4
-6.22%
-5.00K
$12.35
-$76.50K
Jan 18, 2018
75.45K
Sale
ScheduledJan 16 - Jan 17
Form 4
-5.85%
-5.00K
$12.35
-$76.50K
Nov 21, 2017
80.45K
Sale
ScheduledNov 21
Form 4
-10.48%
-10.00K
$8.53
-$200.00K
Oct 26, 2017
85.45K
Sale
ScheduledOct 25
Form 4
-4.98%
-5.00K
$8.53
-$100.00K
Jun 06, 2017
95.45K
Sale
ScheduledJun 05
Form 4
-12.99%
-15.00K
$12.35
-$229.50K
Apr 20, 2017
100.45K
Sale
ScheduledApr 19
Form 4
67.50K
$20.53
$1.39M
Feb 16, 2017
67.50K
Grant
Feb 15
Form 4/A
-28.37%
-10.00K
$17.02
-$246.40K
Oct 19, 2016
25.25K
Sale
ScheduledOct 03
Form 4
-39.60%
-10.00K
$17.02
-$246.40K
Oct 05, 2016
15.25K
Sale
ScheduledOct 03
Form 4
-36.20%
-20.00K
$17.74
-$521.60K
Aug 03, 2016
35.25K
Sale
ScheduledAug 01
Form 4
-8.30%
-5.00K
$15.96
-$112.60K
Jul 06, 2016
55.25K
Sale
ScheduledJul 01
Form 4
30.00K
Feb 29, 2016
30.00K
Grant
Feb 25
Form 4
-14.23%
-10.00K
$17.17
-$249.40K
Jan 06, 2016
60.25K
Sale
ScheduledJan 04
Form 4
55.00K
Dec 22, 2015
55.00K
Grant
Dec 18
Form 4/A
-9.96%
-5.00K
$12.91
-$82.05K
Oct 07, 2015
45.19K
Sale
ScheduledOct 01
Form 4/A
-16.61%
-10.00K
$20.93
-$324.50K
Oct 07, 2015
50.19K
Sale
ScheduledAug 03
Form 4
-9.96%
-5.00K
$12.91
-$82.05K
Oct 02, 2015
45.19K
Sale
ScheduledOct 01
Form 4
-16.61%
-10.00K
$20.93
-$324.50K
Aug 03, 2015
50.19K
Sale
ScheduledAug 03
Form 4
-7.67%
-5.00K
$20.93
-$162.25K
Jul 01, 2015
60.19K
Sale
ScheduledJul 01
Form 4
-7.12%
-5.00K
$17.78
-$130.80K
Apr 03, 2015
65.19K
Sale
ScheduledApr 01 - Apr 01
Form 4
-6.65%
-5.00K
$17.87
-$131.70K
Feb 03, 2015
70.19K
Sale
ScheduledFeb 02
Form 4
40.00K
Dec 16, 2014
40.00K
Grant
Dec 12
Form 4
-6.23%
-5.00K
$12.59
-$78.90K
Oct 02, 2014
75.19K
Sale
ScheduledOct 01
Form 4
-5.87%
-5.00K
$12.61
-$79.10K
Aug 19, 2014
80.19K
Sale
ScheduledAug 18
Form 3
Oct 09, 2013
Showing 28 results

Cullinan Management, Inc.

Chief Medical Officer
Updated Jan 11, 2021
Form 4
116.67K
Jan 11, 2021
116.67K
Grant
Jan 07
Form 3
Jan 07, 2021
Showing 2 results

SUTRO BIOPHARMA, INC.

Investor
Updated Jun 10, 2024
Form 4
35.00K
Jun 10, 2024
35.00K
Grant
Jun 06
Form 4
25.00K
Jun 12, 2023
25.00K
Grant
Jun 08
Form 4
18.50K
Jun 08, 2022
18.50K
Grant
Jun 06
Form 4
18.50K
Jun 07, 2021
18.50K
Grant
Jun 03
Form 4
24.00K
Dec 01, 2020
24.00K
Grant
Nov 30
Form 3
Dec 01, 2020
Showing 6 results

Checkmate Pharmaceuticals, Inc.

Investor
Updated May 31, 2022
Form 4
-100.00%
-20.06K
May 31, 2022
Disposition
May 31
Form 4
20.06K
Feb 01, 2022
20.06K
Grant
Jan 30
Form 3
Feb 01, 2022
Showing 3 results